Clinical data also suggests that expression level of BMAL1 is up-regulated with the increase of ACC malignancy and that higher expression of BMAL1 predicts poor survival probability for patients (Fig. 6a, b). The gene discussed is BMAL1; the disease is adrenal cortex carcinoma.